Skip to main content
Top
Published in: International Journal of Clinical Oncology 2/2010

01-04-2010 | Case Report

Huge pedunculated angiomyofibroblastoma of the vulva

Authors: Kimihiro Nagai, Koji Aadachi, Hitoaki Saito

Published in: International Journal of Clinical Oncology | Issue 2/2010

Login to get access

Abstract

We present the case of a huge pedunculated benign mesenchymal myxoid tumor that developed on the right labia majora of a 48-year-old-woman. The excised mass weighed 4534 g and was 23 cm in diameter; the cut surface was yellowish and elastic. Microscopic examination revealed spindle and plump oval tumor cells arranged with abundant capillary vessels in an edematous stroma. Immunohistochemical staining showed that the tumor cells were positive for vimentin, desmin, estrogen receptor, and progesterone receptor, but negative for α-smooth muscle actin, CD34, CD45, CD68, and S-100. Based on these features, the pathological diagnosis was angiomyofibroblastoma. A pedunculated angiomyofibroblastoma is extremely rare and, to the best of our knowledge, this is the biggest such tumor in terms of size and weight reported to date. It is especially important in such a huge mass greater than 10 cm that angiomyofibroblastoma is differentiated from aggressive angiomyxoma, which is a deeply invasive and recurrent neoplasm.
Literature
1.
go back to reference Granter SR, Nucci MR, Fletcher CDM (2000) Aggressive angiomyxoma: reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases. Histopathology 30:3–10CrossRef Granter SR, Nucci MR, Fletcher CDM (2000) Aggressive angiomyxoma: reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases. Histopathology 30:3–10CrossRef
2.
go back to reference Steeper TA, Rosai J (1983) Aggressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft tissue neoplasm. Am J Surg Pathol 7:463–475PubMed Steeper TA, Rosai J (1983) Aggressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft tissue neoplasm. Am J Surg Pathol 7:463–475PubMed
3.
go back to reference Fletcher CDM, Tsang WYW, Fisher C et al (1992) Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 16:373–382PubMedCrossRef Fletcher CDM, Tsang WYW, Fisher C et al (1992) Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 16:373–382PubMedCrossRef
4.
go back to reference Omori M, Toyoda H, Hirai T et al (2006) Angiomyofibroblastoma of the vulva; a large pedunculated mass formation. Acta Med Okayama 60:237–242PubMed Omori M, Toyoda H, Hirai T et al (2006) Angiomyofibroblastoma of the vulva; a large pedunculated mass formation. Acta Med Okayama 60:237–242PubMed
5.
go back to reference Suzuki M, Hayashi T, Kohira S et al (2008) 2 cases of angiomyofibroblastoma (in Japanese). Nihon Keiseigeka Gakkaizasshi (Jpn J Plast Reconstr Surg) 28:15–23 Suzuki M, Hayashi T, Kohira S et al (2008) 2 cases of angiomyofibroblastoma (in Japanese). Nihon Keiseigeka Gakkaizasshi (Jpn J Plast Reconstr Surg) 28:15–23
6.
go back to reference Tochika N, Takeshita A, Sonobe H et al (2001) Angiomyofibroblastoma of the vulva: report of a case. Surg Today 31:557–559CrossRefPubMed Tochika N, Takeshita A, Sonobe H et al (2001) Angiomyofibroblastoma of the vulva: report of a case. Surg Today 31:557–559CrossRefPubMed
7.
go back to reference Nielsen GP, Young RH, Dickersin GR et al (1997) Angiomyofibroblastoma of the vulva with sarcomatous transformation (Angiomyofibroblastoma). Am J Surg Pathol 21:1104–1108CrossRefPubMed Nielsen GP, Young RH, Dickersin GR et al (1997) Angiomyofibroblastoma of the vulva with sarcomatous transformation (Angiomyofibroblastoma). Am J Surg Pathol 21:1104–1108CrossRefPubMed
8.
go back to reference Sasano H, Date F, Yamamoto H et al (1997) Angiomyofibroblastoma of the vulva: case report with immunohistochemical, ultrastructural and DNA ploidy studies and a review of the literature. Pathol Int 47:647–650CrossRefPubMed Sasano H, Date F, Yamamoto H et al (1997) Angiomyofibroblastoma of the vulva: case report with immunohistochemical, ultrastructural and DNA ploidy studies and a review of the literature. Pathol Int 47:647–650CrossRefPubMed
9.
go back to reference Begin LR, Clement PB, Kirk ME et al (1985) Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases. Hum Pathol 16:621–628CrossRefPubMed Begin LR, Clement PB, Kirk ME et al (1985) Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases. Hum Pathol 16:621–628CrossRefPubMed
10.
go back to reference Nucci MR, Weremowicz S, Sornberger K et al (1999) Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Mod Pathol 12:700 Nucci MR, Weremowicz S, Sornberger K et al (1999) Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Mod Pathol 12:700
11.
go back to reference Hess JL (1998) Chromosomal translocation in benign tumors: the HMGIC proteins. Am J Clin Pathol 109:251–261PubMed Hess JL (1998) Chromosomal translocation in benign tumors: the HMGIC proteins. Am J Clin Pathol 109:251–261PubMed
12.
go back to reference Fetsch JF, Laskin WB, Lefkowitz M et al (1996) Aggressive angiomyxoma. A clinicopathologic study of 29 female patients. Cancer 78:79–90CrossRefPubMed Fetsch JF, Laskin WB, Lefkowitz M et al (1996) Aggressive angiomyxoma. A clinicopathologic study of 29 female patients. Cancer 78:79–90CrossRefPubMed
13.
go back to reference Mortele KJ, Lauwers GJ, Mergo PJ et al (1999) Perineal angiomyofibroblastoma: CT and MRI findings with pathologic correlation. J Comput Assist Tomogr 23:687–689CrossRefPubMed Mortele KJ, Lauwers GJ, Mergo PJ et al (1999) Perineal angiomyofibroblastoma: CT and MRI findings with pathologic correlation. J Comput Assist Tomogr 23:687–689CrossRefPubMed
14.
go back to reference Jeyadevan NN, Sohaib SAA, Thomas JM et al (2002) Imaging features of aggressive angiomyoma. Clin Radiol 58:157–162CrossRef Jeyadevan NN, Sohaib SAA, Thomas JM et al (2002) Imaging features of aggressive angiomyoma. Clin Radiol 58:157–162CrossRef
15.
go back to reference Skalli O, Schurch W, Seemayer T et al (1989) Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 60:275–285PubMed Skalli O, Schurch W, Seemayer T et al (1989) Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 60:275–285PubMed
16.
go back to reference McCluggage WG, Patterson A, Maxwell P (2000) Aggressive angiomyxoma of pelvic parts exhibits oestrogen progesterone receptor positivity. J Clin Pathol 53:603–605CrossRefPubMed McCluggage WG, Patterson A, Maxwell P (2000) Aggressive angiomyxoma of pelvic parts exhibits oestrogen progesterone receptor positivity. J Clin Pathol 53:603–605CrossRefPubMed
17.
go back to reference Laskin WB, Fetsch JF, Tavassoli FA (1997) Angiomyofibroblastoma of the female genital tract: analysis of 17 cases including lipomatous variant. Hum Pathol 28:1046–1055CrossRefPubMed Laskin WB, Fetsch JF, Tavassoli FA (1997) Angiomyofibroblastoma of the female genital tract: analysis of 17 cases including lipomatous variant. Hum Pathol 28:1046–1055CrossRefPubMed
18.
go back to reference MacLean AB, Nicol LA, Hodgins MB (1990) Immunohistochemical localization of estrogen receptors in the vulva and vagina. J Reprod Med 85:1015–1016 MacLean AB, Nicol LA, Hodgins MB (1990) Immunohistochemical localization of estrogen receptors in the vulva and vagina. J Reprod Med 85:1015–1016
Metadata
Title
Huge pedunculated angiomyofibroblastoma of the vulva
Authors
Kimihiro Nagai
Koji Aadachi
Hitoaki Saito
Publication date
01-04-2010
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2010
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0026-0

Other articles of this Issue 2/2010

International Journal of Clinical Oncology 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine